产品
编 号：F473692
分子式：C22H19N5O2
分子量：385.42
分子式：C22H19N5O2
分子量：385.42
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 836683-15-9
产品详情
生物活性：
Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
体内研究：
Acumapimod is an oral low-molecular-weight p38 inhibitor currently in development for the treatment of several inflammatory conditions, including chronic obstructive pulmonary disease (COPD). Intermittent short-term dosing of Acumapimod (75 mg on days 1 and 6) shows a marked improvement in lung function in COPD patients.
体外研究：
Acumapimod is an inhibitor of p38α with an IC50 value of less than 1 μM.
Acumapimod (BCT197) is an orally active p38 MAP kinase inhibitor, with an IC50 of less than 1 μM for p38α.
体内研究：
Acumapimod is an oral low-molecular-weight p38 inhibitor currently in development for the treatment of several inflammatory conditions, including chronic obstructive pulmonary disease (COPD). Intermittent short-term dosing of Acumapimod (75 mg on days 1 and 6) shows a marked improvement in lung function in COPD patients.
体外研究：
Acumapimod is an inhibitor of p38α with an IC50 value of less than 1 μM.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备